paper-with-me

Papers

FlexSBDD: Structure-Based Drug Design with Flexible Protein Modeling

2024-09-29 · Zaixi Zhang, Mengdi Wang, Qi Liu

Structure-based drug design (SBDD), which aims to generate 3D ligand molecules binding to target proteins, is a fundamental task in drug discovery. Existing SBDD methods typically treat protein as rigid and neglect protein structural change when binding with ligand molecules, leading to a big gap with real-world scenarios and inferior generation qualities (e.g., many steric clashes). To bridge the gap, we propose FlexSBDD, a deep generative model capable of accurately modeling the flexible protein-ligand complex structure for ligand molecule generation. FlexSBDD adopts an efficient flow matching framework and leverages E(3)-equivariant network with scalar-vector dual representation to model dynamic structural changes. Moreover, novel data augmentation schemes based on structure relaxation/sidechain repacking are adopted to boost performance. Extensive experiments demonstrate that FlexSBDD achieves state-of-the-art performance in generating high-affinity molecules and effectively modeling the protein's conformation change to increase favorable protein-ligand interactions (e.g., Hydrogen bonds) and decrease steric clashes.

📄 PDF Abstract BibTeX arXiv:2409.19645

Code (0)

등록된 구현이 없습니다.

Tasks

Data AugmentationDrug DesignDrug Discovery

Similar Papers 제목 키워드 기반

DiffBindFR: An SE(3) Equivariant Network for Flexible Protein-Ligand Docking

2023-11-26 · Jintao Zhu, Zhonghui Gu, Jianfeng Pei, Luhua Lai

Molecular docking, a key technique in structure-based drug design, plays pivotal roles in protein-ligand interaction modeling, hit identification and optimization, in which accurate prediction of protein-ligand binding m…

Drug DesignMolecular DockingPose Prediction

Pharmacophore-Conditioned Diffusion Model for Ligand-Based De Novo Drug Design

2025-05-15 · Amira Alakhdar, Barnabas Poczos, Newell Washburn

Developing bioactive molecules remains a central, time- and cost-heavy challenge in drug discovery, particularly for novel targets lacking structural or functional data. Pharmacophore modeling presents an alternative for…

Drug DesignDrug Discovery

NEAT-POCKET: Pocket-Conditioned Autoregressive 3D Molecular Generation with a Neighborhood-Guided Set Transformer

2026-09-04 · Roxane Axel Jacob, Daniel Rose, Thierry Langer, Johannes Kirchmair arxiv

AI-driven de novo molecular design offers a promising route to accelerate early-stage drug discovery by generating novel ligands directly within target protein binding pockets. We present NEAT-POCKET, a pocket-conditione…

Drug Discovery

Tri-graph Information Propagation for Polypharmacy Side Effect Prediction

2020-01-28 · Hao Xu, Shengqi Sang, Haiping Lu

The use of drug combinations often leads to polypharmacy side effects (POSE). A recent method formulates POSE prediction as a link prediction problem on a graph of drugs and proteins, and solves it with Graph Convolution…

Link PredictionPose PredictionPrediction

Attending on Multilevel Structure of Proteins enables Accurate Prediction of Cold-Start Drug-Target Interactions

2025-10-05 · Ziying Zhang, Yaqing Wang, Yuxuan Sun, Min Ye 외 arxiv

Cold-start drug-target interaction (DTI) prediction focuses on interaction between novel drugs and proteins. Previous methods typically learn transferable interaction patterns between structures of drug and proteins to t…

Representation Learning